HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yngvar Fløisand Selected Research

Yngvar Fløisand Research Topics

Disease

9Neoplasms (Cancer)
05/2024 - 03/2007
7Graft vs Host Disease (Graft-Versus-Host Disease)
10/2021 - 01/2010
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 10/2018
4Leukemia
01/2023 - 05/2008
2Lymphoma (Lymphomas)
05/2024 - 01/2018
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 07/2019
2Hematologic Neoplasms (Hematological Malignancy)
01/2019 - 01/2018
2Infections
01/2019 - 09/2014
1GATA2 Deficiency
01/2022
1Crohn Disease (Crohn's Disease)
10/2021
1Ulcerative Colitis
10/2021
1Bronchiolitis Obliterans Syndrome
01/2021
1Atherosclerosis
01/2021
1Lymphoid Leukemia
01/2021
1Atherosclerotic Plaque (Atheroma)
01/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
07/2019
1Hemolysis
01/2019
1Thromboinflammation
01/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2018
1Drug-Related Side Effects and Adverse Reactions
08/2015
1Cytopenia
01/2014
1Bronchiolitis Obliterans
08/2013
1Osteoarthritis
01/2013
1Pathologic Processes
02/2011
1Hyperoxia
02/2011
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2010
1Hematologic Diseases (Blood Diseases)
01/2010
1Opportunistic Infections (Opportunistic Infection)
01/2010
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
03/2004
1Herpes Zoster
03/2004
1Chickenpox
03/2004

Drug/Important Bio-Agent (IBA)

3SteroidsIBA
10/2021 - 01/2017
3vedolizumabIBA
10/2021 - 01/2017
2RNA (Ribonucleic Acid)IBA
01/2023 - 01/2021
1CytokinesIBA
05/2024
1Chimeric Antigen ReceptorsIBA
05/2024
1VaccinesIBA
01/2023
1AntigensIBA
01/2023
1LipidsIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Thomsen-Friedenreich antibodiesIBA
01/2021
1GlobulinsIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2021
1DNA Glycosylases (DNA Glycosylase)IBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Peptides (Polypeptides)IBA
07/2019
1Prothrombin (Factor II)IBA
01/2019
1Complement System Proteins (Complement)IBA
01/2019
1HaptoglobinsIBA
01/2019
1Heme (Haem)IBA
01/2019
1HemopexinIBA
01/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2018
1Proteins (Proteins, Gene)FDA Link
10/2018
1AntibodiesIBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1Immunoglobulin FragmentsIBA
01/2018
1Rituximab (Mabthera)FDA Link
01/2018
1Single-Chain AntibodiesIBA
01/2018
1IntegrinsIBA
01/2017
1Glutathione Transferase (Glutathione S-Transferase)IBA
08/2015
1eltrombopagFDA Link
01/2014
1Thrombopoietin ReceptorsIBA
01/2014
1Carbon DioxideIBA
02/2011
1Galectins (Galectin)IBA
02/2011
1Galectin 1 (LGALS1)IBA
02/2011
1Oxygen (Dioxygen)IBA
02/2011
1Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2008
1Toll-Like Receptor AgonistsIBA
10/2007
1Alemtuzumab (Campath)FDA Link
03/2004
1Antiviral Agents (Antivirals)IBA
03/2004

Therapy/Procedure

5Hematopoietic Stem Cell Transplantation
01/2023 - 01/2010
4Stem Cell Transplantation
01/2021 - 03/2007
3Drug Therapy (Chemotherapy)
01/2023 - 05/2008
2Induction Chemotherapy
01/2023 - 01/2023
2Cell Transplantation
10/2021 - 01/2019
2Transplantation
09/2014 - 01/2010
2Therapeutics
01/2013 - 02/2011
1Traction
12/2023
1Intravenous Injections
01/2018
1Lung Transplantation
08/2013